Effect of the oral leukotriene antagonist, ICI 204,219, on antigen-induced bronchoconstriction in subjects with asthma.

[1]  K. P. Hui,et al.  Lung function improvement in asthma with a cysteinylleukotriene receptor antagonist , 1991, The Lancet.

[2]  C. Dollery,et al.  Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects , 1991, The Lancet.

[3]  R. Patterson,et al.  The effect of the oral leukotriene antagonist, ICI 204,219, on leukotriene D4 and histamine-induced cutaneous vascular reactions in man. , 1991, The Journal of allergy and clinical immunology.

[4]  P. O'Byrne,et al.  Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist. , 1990, The New England journal of medicine.

[5]  Paul H. Rubin,et al.  The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air. , 1990, The New England journal of medicine.

[6]  L. Smith,et al.  Inhibition of leukotriene D4-induced bronchoconstriction in normal subjects by the oral LTD4 receptor antagonist ICI 204,219. , 1990, The American review of respiratory disease.

[7]  C T Dollery,et al.  Effect of the oral leukotriene D4 antagonist LY171883 on inhaled and intradermal challenge with antigen and leukotriene D4 in atopic subjects. , 1989, The Journal of allergy and clinical immunology.

[8]  S. Holgate,et al.  Effect of a thromboxane receptor antagonist on PGD2- and allergen-induced bronchoconstriction. , 1989, Journal of applied physiology.

[9]  R. Hall,et al.  Pharmacologic profile of SK&F 104353: a novel, potent and selective peptidoleukotriene receptor antagonist in guinea pig and human airways. , 1987, The Journal of pharmacology and experimental therapeutics.

[10]  S P Hanley,et al.  The effect of an oral leukotriene D4 antagonist L-649,923 on the response to inhaled antigen in asthma. , 1987, The Journal of allergy and clinical immunology.

[11]  V. Popa.  The classic antihistamines (H1 blockers) in respiratory medicine. , 1986, Clinics in chest medicine.

[12]  P. O'Byrne,et al.  Airway responsiveness to leukotrienes C4 and D4 and to methacholine in patients with asthma and normal controls. , 1986, The New England journal of medicine.

[13]  R. Patterson,et al.  Characterization of the airway response to inhaled leukotriene D4 in normal subjects. , 1986, The American review of respiratory disease.

[14]  R. Patterson,et al.  The effect of inhaled leukotriene D4 in humans. , 1985, The American review of respiratory disease.

[15]  E. R. Mcfadden,et al.  Airway constriction in normal humans produced by inhalation of leukotriene D. Potency, time course, and effect of aspirin therapy. , 1983, JAMA.

[16]  E. R. Mcfadden,et al.  Effects of leukotriene D on the airways in asthma. , 1983, The New England journal of medicine.

[17]  N. Thomson,et al.  Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway caliber. , 1982, The Journal of allergy and clinical immunology.

[18]  J. Fish,et al.  Measurements of responsiveness in bronchoprovocation testing. , 1979, The Journal of allergy and clinical immunology.

[19]  S. Spector,et al.  Standardization of bronchial inhalation challenge procedures. , 1975, The Journal of allergy and clinical immunology.